Form4.ai tracks every SEC insider trade in real time. See every TVTX insider filing with a free account — no card.
See every TVTX insider filing — free account, no card.
Free accountTravere Therapeutics, Inc. (TVTX) has 10 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $45.7M. Most recent filing: Oct. 19, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 19, 2026 SEC filing | Dube Eric M CHIEF EXECUTIVE OFFICER | Cashless exercise | $6,565,074 | — |
| Sep 17, 2026 SEC filing | ROTE WILLIAM E. Chief Research Officer | Sold | $1,102,617 | — |
| Sep 17, 2026 SEC filing | REED ELIZABETH E Chief Legal Officer and GC | Cashless exercise | $1,757,945 | — |
Create a free account to see all 10 TVTX filings from the last 90 days. No card needed.
Create free accountWant TVTX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.